𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoclonal antibody-mediated solid-phase assay for mammalian O6-alkylguanine DNA alkyltransferase activity

✍ Scribed by Masahiko S. Satoh; Chieko Moriyama; Akira Asai; Hiroshi Handa; Manfred F. Rajewsky; Toshio Kuroki; Nam-ho Huh


Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
787 KB
Volume
196
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.

✦ Synopsis


We describe a sensitive, rapid, and simple assay for mammalian O6-alkylguanine DNA alkyltransferase (O6-AGT) utilizing solid-phase DNA as the substrate and a monoclonal antibody (Mab)-based immuno-slotblot (ISB) for quantitation of O6-ethylguanine (O6-EtG). lambda-phage DNA was treated with N-ethyl-N-nitrosourea and immobilized on newly developed hydrophilic latex beads. After incubation with cell extracts to be assayed for O6-AGT activity, the substrate DNA could be isolated easily by a brief centrifugation through 50% glycerol. The amount of O6-EtG retained in the substrate DNA was determined by ISB using the anti-(O6-ethyl-2'-deoxyguanosine) Mab ER-6. As little as 2 fmol of O6-AGT per reaction tube can be reproducibly measured by this procedure, which is suitable for handling large numbers of samples within a short time (e.g., 80 samples within 2 days). In normal and malignant cells, respectively, O6-AGT activity protects against O6-alkylguanine-mediated mutagenesis and oncogenesis following exposure to N-nitroso carcinogens or confers resistance against cytocidal anti-cancer drugs such as chloroethylnitrosoureas and related compounds. The analysis of cellular O6-AGT activity by a highly sensitive, routinely applicable method is, therefore, of particular interest in studies related to carcinogenesis, molecular epidemiology, and clinical oncology.


📜 SIMILAR VOLUMES


Synthesis of three no-carrier-added O6-4
✍ Emmanuelle Mounetou; Catherine Cussac; Frédérique Mathieu; Jean-Claude Maurizis; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 461 KB

## Abstract O^6^‐alkylguanine‐DNA alkyltransferase (AGT) is mainly responsible for tumour resistances observed in chemotherapeutic treatments by chloroethylnitrosoureas (CENUs). Measurement of AGT activity is thereby essential to predict the response of the patients to therapy with CENUs. In order